The taxane molecules extracted from the bark of trees from the genus demonstrate anticancer activity and are the main components of the drug paclitaxel. Even though a great deal of research has been carried out to produce them synthetically, this manufacturing is still dependent on cell culture. Furthermore, these processes are not suitable for steady taxane production. Therefore, the search for alternative sources of taxane production has generated growing interest amongst the scientific community. The use of endophytic fungi for the obtention of taxane constitutes an attractive alternative. Here, we present an analysis of the taxane production of several microorganisms through LC-QTOF MS/MS. We isolated 21 endophytic fungus strains, identified through sequencing of their internal transcribed spacer region (ITS). The phylogenetic analysis showed the presence of 11 different genera, namely , , , , , , , , , , and . These fungi have been previously described to synthetize distinct metabolites of medical interest, hence supporting the study of their potential taxane production. Here, we report the production of taxadiene by some of these fungi, namely sp. (1.35 μg/L) TgO (0.7 μg/L) (0.13 μg/L), and sp. (0.3 μg/L). Furthermore, we also detected the production of baccatin III, a crucial precursor component of the drug paclitaxel. This is the first report of taxane production by fungi phylogenetically related to the and genera.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11858034 | PMC |
http://dx.doi.org/10.3390/microorganisms13020300 | DOI Listing |
Clinicoecon Outcomes Res
March 2025
CliCon S.r.l., Società Benefit, Health, Economics & Outcomes Research, Bologna, 40137, Italy.
Purpose: To describe patients with hormone receptor positive and human epidermal growth factor receptor 2 negative metastatic breast cancer (HR+/HER2- mBC) in Italy for demographic and clinical variables, comorbidity profile, metastases and therapeutic pathways.
Patients And Methods: From 2017 to 2021, HR+/HER2- mBC patients were extrapolated from administrative databases of healthcare entities covering a catchment area of about 3 million health-assisted women. The study included patients with a hospital discharge diagnosis for mBC; with specific prescriptions of therapies for HR+; without HER2-targeted therapy; with at least one prescription for CDK4/6 inhibitors.
BMJ Open
March 2025
Department of Pharmacy, Yantai Yuhuangding Hospital, Yantai, Shandong, China
Objectives: Penpulimab is a novel programmed death-1 (PD-1) inhibitor that has been approved in China for use in combination with chemotherapy as a first-line treatment for locally advanced or metastatic squamous non-small cell lung cancer (sq-NSCLC). However, the cost-effectiveness of this treatment in China remains to be determined. In this study, we aimed to assess the cost-effectiveness of penpulimab combined with paclitaxel and carboplatin for metastatic sq-NSCLC.
View Article and Find Full Text PDFMicroorganisms
January 2025
Laboratorio de Bioingeniería-UNIDA, Tecnológico Nacional de México, Instituto Tecnológico de Veracruz, Veracruz 91897, Veracruz, Mexico.
The taxane molecules extracted from the bark of trees from the genus demonstrate anticancer activity and are the main components of the drug paclitaxel. Even though a great deal of research has been carried out to produce them synthetically, this manufacturing is still dependent on cell culture. Furthermore, these processes are not suitable for steady taxane production.
View Article and Find Full Text PDFInt J Nanomedicine
February 2025
Department of Hepatobiliary-Pancreatic and Integrative Oncology, Minhang Branch, Fudan University Shanghai Cancer Center, Shanghai, 200240, People's Republic of China.
Introduction: Lung cancer, a deadly malignancy, often employs Docetaxel (DTX) as a chemotherapy option. However, DTX non-selective distribution limits its therapeutic effectiveness due to adverse side effects. This study aims to develop novel folate-targeted albumin polyester nanocarriers (FA-DTX-APs) encapsulating DTX for precise delivery, enhancing lung cancer treatment efficacy.
View Article and Find Full Text PDFInt J Nanomedicine
February 2025
College of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, 050018, People's Republic of China.
Background: Paclitaxel-induced blood system disorders and peripheral neuropathy impede the progress of new formulations in clinical trials.
Purpose Of Study: To mitigate these adverse effects by developing and validating a prodrug strategy that encapsulates a glucose-paclitaxel conjugate within nanomicelles.
Material And Methods: Succinic anhydride was used as a bridge to couple C2'-paclitaxel with methyl 2'-glucopyranose and prepare a glucose-paclitaxel conjugate.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!